Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia.
ACS Chem Biol. 2020 Aug 21;15(8):2070-2078. doi: 10.1021/acschembio.0c00218. Epub 2020 Jul 20.
A wide range of drug targets can be effectively modulated by peptides and macrocycles. Unfortunately, the size and polarity of these compounds prevents them from crossing the cell membrane to reach target sites in the cell cytosol. As such, these compounds do not conform to standard measures of drug-likeness and exist in beyond the rule-of-five space. In this work, we investigate whether prodrug moieties that mask hydrogen bond donors can be applied in the beyond rule-of-five domain to improve the permeation of macrocyclic compounds. Using a cyclic peptide model, we show that masking hydrogen bond donors in the natural polar amino acid residues (His, Ser, Gln, Asn, Glu, Asp, Lys, and Arg) imparts membrane permeability to the otherwise impermeable parent molecules, even though the addition of the masking group increases the overall compound molecular weight and the number of hydrogen bond acceptors. We demonstrate this strategy in PAMPA and Caco2 membrane permeability assays and show that masking with groups that reduce the number of hydrogen-bond donors at the cost of additional mass and hydrogen bond acceptors, a donor-acceptor swap, is effective.
肽和大环化合物可有效调节多种药物靶点。但这些化合物的大小和极性会阻止它们穿过细胞膜,到达细胞胞质中的靶位。因此,这些化合物不符合标准的类药性衡量标准,处于“五规则”之外的空间。在这项工作中,我们研究了是否可以将掩蔽氢键供体的前药部分应用于“五规则”之外的区域,以改善大环化合物的渗透。我们使用环状肽模型表明,掩蔽天然极性氨基酸残基(His、Ser、Gln、Asn、Glu、Asp、Lys 和 Arg)中的氢键供体,可使原本不可渗透的母体分子具有膜透过性,尽管添加掩蔽基团会增加化合物的总分子量和氢键受体的数量。我们在 PAMPA 和 Caco2 膜通透性测定中证明了这一策略,并表明用减少氢键供体数量的基团进行掩蔽会有效,尽管这会增加额外的质量和氢键受体,从而实现供体-受体交换。